Aneurysmal subarachnoid hemorrhage in the elderly:

Similar documents
Long-Term Excess Mortality After Aneurysmal Subarachnoid Hemorrhage Patients With Multiple Aneurysms at Risk

Multiple intracranial aneurysms: incidence and outcome in a series of 357 patients

Epidemiology And Treatment Of Cerebral Aneurysms At An Australian Tertiary Level Hospital

Extent of subarachnoid hemorrhage and development of hydrocephalus

Definition พ.ญ.ส ธ ดา เย นจ นทร. Epidemiology. Definition 5/25/2016. Seizures after stroke Can we predict? Poststroke seizure

Treatment of Acute Hydrocephalus After Subarachnoid Hemorrhage With Serial Lumbar Puncture

Effect of early operation for ruptured aneurysms on prevention of delayed ischemic symptoms

A Less Invasive Approach for Ruptured Aneurysm with Intracranial Hematoma: Coil Embolization Followed by Clot Evacuation

Clinical Review of 20 Cases of Terson s Syndrome

(aneurysmal subarachnoid hemorrhage, 17%~60% :SAH. ,asah , 22%~49% : Willis. :1927 Moniz ;(3) 2. ischemic neurological deficit,dind) SAH) SAH ;(6)

lek Magdalena Puławska-Stalmach

Summary of some of the landmark articles:

Treatment of Unruptured Vertebral Artery Dissecting Aneurysms

The frequency of subarachnoid hemorrhage from very small cerebral aneurysms (<5mm): A population based study

Moyamoya Syndrome with contra lateral DACA aneurysm: First Case report with review of literature

Subarachnoid Hemorrhage and Brain Aneurysm

Clinical Analysis of Risk Factors Affecting Rebleeding in Patients with an Aneurysm. Gab Teug Kim, M.D.

Effect of clot removal on cerebral vasospasm TETSUJI INAGAWA, M.D., MITSUO YAMAMOTO, M.D., AND KAZUKO KAMIYA, M.D.

Neurosurgical decision making in structural lesions causing stroke. Dr Rakesh Ranjan MS, MCh, Dip NB (Neurosurgery)

Coiling of ruptured and unruptured intracranial aneurysms

Neurointensive Care of Aneurysmal Subarachnoid Hemorrhage. Alejandro A. Rabinstein Department of Neurology Mayo Clinic, Rochester, USA

Method Hannah Shotton

A discussion of the optimal treatment of intracranial aneurysm rupture in elderly patients

Sub-arachnoid haemorrhage

Brain AVM with Accompanying Venous Aneurysm with Intracerebral and Intraventricular Hemorrhage

Management of Cerebral Aneurysms in Polycystic Kidney Disease. Dr H Stockley Consultant Neuroradiologist Greater Manchester Neuroscience Centre

Prognostic Factors for Outcome in Patients With Aneurysmal Subarachnoid Hemorrhage

Preoperative Grading Systems of Spontaneous Subarachnoid Hemorrhage

Trigger factors for rupture of intracranial aneurysms in relation to patient and aneurysm characteristics

Small and medium size intracranial aneurysms - a 5 years retrospective analysis trial and multimodal treatment

What You Should Know About Cerebral Aneurysms

NIH Public Access Author Manuscript J Am Coll Radiol. Author manuscript; available in PMC 2013 June 24.

TCD AND VASOSPASM SAH

Canadian Best Practice Recommendations for Stroke Care. (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management

はじめに 対象と方法 39: , 2017 SAH 183 WFNS

Distal anterior cerebral artery (DACA) aneurysms are. Case Report

Comparison of Five Major Recent Endovascular Treatment Trials

Endovascular Treatment of Cerebral Arteriovenous Malformations. Bs. Nguyễn Ngọc Pi Doanh- Bs Đặng Ngọc Dũng Khoa Ngoại Thần Kinh

AEROMEDICAL DECISION MAKING IN CEREBRAL ANEURYSMS. Pooshan Navāthé Michael Drane Peter Clem David Fitzgerald

SAH READMISSIONS TO NCCU

The incidence of subarachnoid hemorrhage (SAH) increases

Guideline scope Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management

Long term follow-up of patients with coiled intracranial aneurysms Sprengers, M.E.S.

Interventions in the Management of Acute Stroke. Dr Md Shafiqul Islam Associate Professor Neurosurgery Dhaka Medical College Hospital

Intracranial aneurysms are an important health problem

Endovascular Treatment of Symptomatic Vertebral Artery Dissecting Aneurysms

Correlation of revised fisher scale with clinical

Division of Neurosurgery, Institute of Brain Diseases, Tohoku University School of Medicine, Sendai 982

[(PHY-3a) Initials of MD reviewing films] [(PHY-3b) Initials of 2 nd opinion MD]

Clinic of Geriatrics, Faculty of Health Sciences, Collegium Medicum, Nicolaus Copernicus University, Toruń, Poland 3

Intracranial aneurysms are being treated with increasing frequency. Treatment of Poor-Grade Subarachnoid Hemorrhage Trial

Bilateral blunt carotid artery injury: A case report and review of the literature

7/18/2018. Cerebral Vasospasm: Current and Emerging Therapies. Disclosures. Objectives

Stroke & the Emergency Department. Dr. Barry Moynihan, March 2 nd, 2012

Risk Factors Associated with Cerebral Vasospasm following Aneurysmal Subarachnoid Hemorrhage

Small UIAs, <7 mm in diameter, uncommonly cause aneurysmal symptoms and are the most frequently detected incidentally.

Received: 15 September 2014 /Accepted: 20 November 2014 /Published online: 6 December 2014 # Springer-Verlag Berlin Heidelberg 2014

UPSTATE Comprehensive Stroke Center. Neurosurgical Interventions Satish Krishnamurthy MD, MCh

Chapter Five. Anosmia after aneurysmal subarachnoid hemorrhage. M.J.H. Wermer, M. Donswijk, P. Greebe, B. Verweij and G.J.E.

Modern Management of ICH

The standard examination to evaluate for a source of subarachnoid

TRAUMATIC CAROTID &VERTEBRAL ARTERY INJURIES

INTRACEREBRAL HEMORRHAGE FOLLOWING ENUCLEATION: A RESULT OF SURGERY OR ANESTHESIA?

Intra-arterial nimodipine for the treatment of vasospasm due to aneurysmal subarachnoid hemorrhage

Antithrombotic therapy in patients with transient ischemic attack / stroke (acute phase <48h)

Subarachnoid Hemorrhage (SAH) Disclosures/Relationships. Click to edit Master title style. Click to edit Master title style.

THE EFFICACY AND SAFETY OF CILOSTAZOL IN SUBARACHNOID HEMORRHAGE. A META- ANALYSIS OF RANDOMIZED AND NON RANDOMIZED STUDIES DR. MUHAMMAD F.

Neurosurgical Management of Stroke

Cryptogenic Strokes: Evaluation and Management

Studying Aneurysm Devices in the Intracranial Neurovasculature

In patients with a symptomatic intracranial aneurysm,

Multi-modality management of intracranial aneurysms

Age-Associated Vasospasm in Aneurysmal Subarachnoid Hemorrhage

Dept. of Neurosurgery, Division of Endovascular Neurosurgery, Medilaser Clinic, Tunja, Colombia 2

What Is the Significance of a Large Number of Ruptured Aneurysms Smaller than 7 mm in Diameter?

STUDY OF C-REACTIVE PROTEIN IN ACUTE ISCHEMIC STROKE Medhini V. J 1, Hally Karibasappa 2

TREATMENT OF INTRACRANIAL ANEURYSMS

Paul Gigante HMS IV Gillian Lieberman, MD. Sept Mr. T s T s Headache. Paul Gigante,, Harvard Medical School Year IV Gillian Lieberman, MD

Impact of a Protocol for Acute Antifibrinolytic Therapy on Aneurysm Rebleeding After Subarachnoid Hemorrhage

Emergency Department Stroke Registry Indicator Specifications 2018 Report Year (07/01/2017 to 06/30/2018 Discharge Dates)

Primary Versus Comprehensive: What is the Difference?

WHITE PAPER: A GUIDE TO UNDERSTANDING SUBARACHNOID HEMORRHAGE

The Worst Headache of My Life Hemorrhagic Stroke

Update in Diagnosis and Management of Intracranial Aneurysms for Primary Health Care Providers November 15, 2012 Boston, Massachusetts

Assessment of Vasospasm and Delayed Cerebral Ischemia after Subarachnoid Hemorrhage: Current concepts and Value of CT Perfusion and CT Angiography

Referral bias in aneurysmal subarachnoid hemorrhage

The natural history of incidental unruptured intracranial

Stroke 101. Maine Cardiovascular Health Summit. Eileen Hawkins, RN, MSN, CNRN Pen Bay Stroke Program Coordinator November 7, 2013

Factors Related to the Development of Shunt-Dependent Hydrocephalus Following Subarachnoid Hemorrhage in the Elderly

Endovascular treatment with coils has become an established

Aneurysms of the posterior inferior cerebellar artery

Detectability of unruptured intracranial aneurysms on thinslice non-contrast-enhanced CT

Surgical clipping as the preferred treatment for aneurysms of the middle cerebral artery

Management and Investigation of Ischemic Stroke By Etiology

Fundus findings in spontaneous subarachnoid hemorrhage and their correlation with neurologic characteristics

Index. average stress 146. see ACIS

Prognostic Factors in Patients who Underwent Aneurysmal Clipping due to Spontaneous Subarachnoid Hemorrhage

Perioperative Management Of Extra-Ventricular Drains (EVD)

CLEAR III TRIAL : UPDATE ON SURGICAL MATTERS THAT MATTER

Current State of the Art

Transcription:

Aneurysmal subarachnoid hemorrhage in the elderly: Helsinki experience 1980-2008 Eljas Supponen, BM Student number: 013302559 Helsinki 04.05.2012 Thesis eljas.supponen@helsinki.fi Supervisors: Martin Lehecka, M.D., Ph.D. Riku Kivisaari, M.D., Ph.D. Päivi Koroknay-Pál, M.D., Ph.D. University of Helsinki Faculty of Medicine

Faculty Department Faculty of Medicine Institution of Clinical Medicine Eljas Supponen Author Title Aneurysmal subarachnoid hemorrhage in the elderly: Helsinki experience 1980-2008 Medicine Subject Level Month and year -Sidoantal - Number of pages Thesis May 2012 33

T Abstract Objective The number of elderly patients with aneurysmal subarachnoid hemorrhage (asah) is increasing but their prognosis remains unsatisfactory. Our aim is to determine which patients are most likely to benefit from active treatment. Methods Between 1980 and 2008, 289 patients aged 70 years were treated for asah at the Department of Neurosurgery, Helsinki University Central Hospital (HUCH). We assessed the functional outcome at three months and the mortality at one year after asah. Results Only 30% of actively treated patients had favorable outcome with a one year fatality rate of 36%. Predictive factors of favorable outcome included good initial clinical grade and the absence of intraventricular and intracerebral hemorrhage. Medical complications were associated with unfavorable outcome. Conclusion Elderly asah patients have often poor prognosis. Severity of the SAH is the most important determinant of outcome. Active treatment decreases mortality and should be offered to patients with good initial clinical condition. (150 words) Avainsanat Nyckelord Keywords Aneurysmal subarachnoid hemorrhage, Aneurysm treatment, Elderly, Follow-up, Intracranial aneurysm, Outcome Säilytyspaikka Förvaringställe Where deposited Muita tietoja Övriga uppgifter Additional information

Table of Contents 1 INTRODUCTION... 1 2 PATIENTS AND METHODS... 3 2.1 Patients...4 2.2 Aneurysms...5 2.3 Treatment...5 2.4 Follow-up...6 2.5 Statistical methods...8 3 RESULTS... 9 3.1 Outcome after active treatment...9 3.1.2 Age and outcome... 11 3.1.3 Medical history... 11 3.1.4 Clinical grade... 11 3.1.5 ICH and IVH... 12 3.1.6 Aneurysm size and location... 13 3.1.7 Clipping vs. coiling... 14 3.1.8 Medical complications... 15 3.2 Conservatively treated patients... 15 4 DISCUSSION...18 4.1 Age and asah... 18 4.2 Age and out come... 19 4.3 Factors related to favorable outcome... 19 4.4 Aneurysm location and size and outcome... 20 4.5 Medical history and outcome... 20

4.6 Factors related to unfavorable out come... 21 4.7 Rebleeding, vasospasm and chronic hydrocephalus... 21 4.8 Conservative treatment... 22 4.9 Endovascular and microneurosurgical treatment... 23 4.10 Limitations of this study... 23 5 CONCLUSION...25 6 REFERENCES...26

1 Introduction Advanced age is an important risk factor for poor outcome in patients who suffer subarachnoid hemorrhage (SAH) caused by the rupture of an intracranial aneurysm (1). The incidence of aneurysmal SAH (asah) increases with age (2). Since the 1970s, the mean age of asah patients has been increasing. Nowadays, the mean age is closer to 60 than 50 years of age (3). In the meantime the percentage of senior citizens within the general population is growing quickly in many Western countries, so patients aged 70 years may comprise as much as 20-25% of all asah cases (4). In Finland, with a population of 5 million, this corresponds to an estimate of more than 200 cases per year (3). Therefore, the management of asah in the elderly has become an important issue. Treatment of elderly patients with SAH is challenging because of pre-existing medical conditions and multiple medications. Elderly SAH patients tend to be in worse condition on admission, they have a thicker subarachnoid blood clot on the computed tomography (CT) scan (5), and they develop delayed neurological deficits and hydrocephalus more frequently compared to younger patients (6). In addition, the elderly patients have a shorter life expectancy and decreased neuronal plasticity to help them recover. As a result, the outcome of elderly asah patients is in many cases poorer compared to their younger peers. However, with active treatment some elderly patients, especially those in good initial clinical condition, can expect similar outcome as younger patients (7,8). It is still unclear which occlusion method for the ruptured aneurysm would be more favorable in the elderly, microneurosurgical clipping or endovascular coiling. This retrospective study reflects the management of asah in the elderly over the past three decades in Finland. We analyzed the characteristics of 289 asah patients aged 70 years treated in Helsinki University Central Hospital, Department of Neurosurgery during 1980-2008. We focused on finding predictive factors related to good and poor outcome. Furthermore, we defined more clearly the relationship between clinical characteristics and outcome after asah in elderly

patients. Our aim was to identify those patients who would benefit from active treatment.

2 Patients and Methods Helsinki Cerebral Aneurysm database contains data of all intracranial aneurysm patients admitted to Helsinki University Central Hospital (HUCH) in 1937-2008. HUCH is the largest neurosurgical center in Finland and alone covers a population of 1.8 million in Southern Finland. The total of nearly 9000 aneurysm patients makes it one of the largest databases of its kind in the world. From the database, we retrieved the data of 413 patients who were 70 years old at the time of diagnosis, and who were admitted to HUCH between 1.1.1980 31.12.2008. During this period of 29 years CT imaging was routine in HUCH. These 413 patients represent 8% of all aneurysm patients treated in HUCH during the same period. Among the 413 patients, 17 (4%) had fusiform or dissecting aneurysms and they were excluded. Of the remaining 396 saccular aneurysm patients, 107 were treated for unruptured aneurysm(s) only (Figure 1). In this study we focused on the 289 patients who were treated for asah. They represent 7% of all asah patients treated in HUCH during this period. Both clinical and radiological data of the patients were reviewed. The diagnosis of SAH was confirmed by CT scan or lumbar puncture. The aneurysms were identified using digital subtraction angiography (DSA), CT angiography (CTA) or magnetic resonance angiography (MRA). Severity of the subarachnoid hemorrhage was expressed using the Fisher scale (9). The initial clinical condition was assessed using Hunt & Hess (HH) and World Federation of Neurosurgical Societies (WFNS) grading scales (10,11). The initial clinical condition was categorized according to Hunt and Hess scale as good (grade I-III) or poor (grade IV-V).

Figure 1. Patient selection. 2.1 Patients Characteristics of the 289 patients with asah are shown in Table 1. The mean age at time of diagnosis was 75 years (median 75, range 70-92 years). The majority of the patients were female (78%). Half of the patients had a history of hypertension and a quarter had cardiac disease. Every tenth patient had suffered a stroke or transient ischemic attack prior to the asah and just as many were taking statins. Almost a fifth of the patients had aspirin medication (51 cases, 18%) but only 15 patients (5%) were on warfarin.

2.2 Aneurysms Altogether, 397 aneurysms were found in the 289 patients with asah. There were 211 (73%) patients with a single aneurysm, 54 (19%) with two aneurysms, 18 (6%) with three aneurysms and 6 (2%) with four aneurysms. In other words, multiple aneurysms were found in 78 (27%) cases. Ruptured aneurysms were divided into four groups according to size. Most of the ruptured aneurysms (240 cases, 83%) were <15mm in size, the median being 8mm. Four patients (1%) had rupture of a giant aneurysm ( 25mm). The location of the ruptured aneurysm was divided into five groups: internal carotid artery (ICA), middle cerebral artery (MCA), anterior communicating artery and proximal anterior cerebral artery (AcomA), pericallosal artery, and posterior circulation (including vertebral, basilar, cerebellar and posterior cerebral arteries). The most common locations for the ruptured aneurysms were the AcomA, MCA and ICA which accounted for 82 (28%), 81 (27%) and 79 (27%) cases, respectively. 2.3 Treatment Microneurosurgical clipping was the treatment of choice for 206 patients (71%), 35 patients (12%) had endovascular embolization of the ruptured aneurysm, and 37 patients (13%) were treated conservatively. The most common reason for choosing conservative treatment was expected poor prognosis because of poor initial clinical grade: this was the case in 17 (46%) conservatively treated patients. Other reasons for conservative treatment included old age in eight (22%) cases, death before treatment in five (14%) cases and patient refusing surgical treatment in three (8%) cases.

2.4 Follow-up The Glasgow Outcome Score (GOS) was used to evaluate functional outcome at three months after the SAH (12). Outcome was divided into two categories: favorable (GOS 4-5); and unfavorable (GOS 1-3). The functional outcome was evaluated at three months for 205 patients. Eighty one patients had no follow-up after discharge and data was missing in three patients. Mortality was evaluated in both conservatively and actively treated group at one year after the acute onset of asah. The follow-up for the conservatively treated patients was based on mortality since only 24% (n=9) were evaluated clinically at 3 months. Death certificates were reviewed and vital status data at the end of the year 2008 were obtained from the Population Register Center of Finland, which contains information on all the people living in Finland. Table 1. Characteristics of 289 patients aged 70 years with SAH caused by the rupture of a saccular aneurysm. n (%) Total 289 (100) Sex Female 226 (78) Male 63 (22) Medical history Hypertension 142 (49) Cardiac disease 71 (25) Respiratory disease 23 (8) Current smoker 27 (9) Prior medication Oral anticoagulant 15 (5) Aspirin 51 (18) LMWH 1 (0) Clopidogrel 2 (1) Statin 31 (11) Prior stroke or TIA 31 (11) Prior functional status Independent 268 (93) Dependent 6 (2) Data missing 15 (5) Number of aneurysms 1 211 (73) 2 78 (27)

Location of ruptured aneurysm ICA 79 (27) MCA 81 (28) AcomA & A1 82 (28) Pericallosal artery 14 (5) Posterior circulation 33 (11) Size of ruptured aneurysm 7mm 130 (45) 7-13mm 103 (36) >13mm 40 (14) Data missing 16 (6) Treatment Clipping 206 (71) Embolization 35 (12) Other 11 (4) Conservative treatment 37 (13) Initial HH 1 17 (6) 2 105 (36) 3 64 (22) 4 66 (23) 5 30 (10) Data missing 7 (2) Initial WFNS 1 121 (42) 2 56 (19) 3 20 (7) 4 41 (14) 5 44 (15) Data missing 7 (2) CT Fisher scale No blood 10 (3) Blood <1mm 29 (10) Blood 1mm 80 (28) ICH and/or IVH ± SAH 139 (48) Data missing 31 (11) CT findings ICH 93 (32) IVH 85 (29) ICH and IVH 41 (14) SDH 12 (4) Acute hydrocephalus 135 (47) LMWH, low molecular weight heparin; TIA, transient ischemic attack; ICA, internal carotid artery; MCA, middle cerebral artery; AcomA, anterior communicating artery; A1, first segment of the anterior cerebral artery; HH, Hunt & Hess grade;

WFNS, World Federation of Neurosurgical Societies grading scale; CT, computed tomography; ICH, intracerebral hemorrhage; IVH, intraventricular hemorrhage; SDH, subdural hematoma 2.5 Statistical methods Data analysis was performed using IBM SPSS Statistics 20 software. The significance level was set at p 0.05. The Fisher s exact test was used to analyze the relationships between prognostic factors and outcome. The aneurysm database has approval of the Ethics Committee of the HUCH (D number 469/E0/04).

3 Results Over the study period, there was a clear trend for an increase in the proportion of 70 year old patients with asah admitted to the Department of Neurosurgery in HUCH. During the first half of the study period in 1980-1993, there were only 13 admissions (4%) compared to 276 admissions (96%) in the second half in 1994-2007. During the 1980 s there were virtually no elderly asah patients admitted to HUCH at all and it wasn t until the late 1990 s that the proportion of elderly patients started to grow reaching an average of 14% during 2000-2007. Figure 2. Bar graph showing an increase in the proportion of elderly patients with aneurysmal subarachnoid hemorrhage admitted in 1980-2007. 3.1 Outcome after active treatment Actively (n=252) and conservatively (n=37) treated patients were analyzed as separate groups, with main focus on the active treatment. Of the 252 actively

treated patients with asah, 30% (n=76) achieved favorable outcome and 69% (n=174) had unfavorable outcome at the three month follow-up. The fatality rate at three months was 30% (76 deaths). The fatality rate at one year after discharge was 36% (91 deaths). The most common cause of death during the first year was asah accounting for 86% (n=78) deaths. Five patients (6%) died of cardiovascular causes and three patients (3%) died of cerebrovascular disease other than asah. The median duration of postoperative neurosurgical care was 5 days at the ICU and 14 days at the ward before transfer to another hospital. There were a total of 21 (8%) in-hospital deaths, all caused by SAH. At discharge, 90% (n=228) patients had unfavorable outcome (GOS 1-3) and only 8% (n=20) patients had favorable outcome (GOS 4-5). Preoperative rebleeding of the ruptured aneurysm was diagnosed in 17% (n=43) of patients despite early treatment. The majority of patients (71%, n=175) had their aneurysm operated 0-3 days after the onset of asah. The median delay for operation after bleeding was one day. There were three patients who had their aneurysm operated more than a year after SAH because their primary treatment had taken place in a hospital excluded from this study. Surprisingly, the occurrence of rebleeding did not demonstrate a significant effect on outcome. Clinically relevant vasospasm occurred in 13% (n=33) of patients. These patients tended to have more often unfavorable outcome compared to patients who avoided vasospasm, 79% (n=26) and 68% (n=148), respectfully. This result was not statistically significant. Hydrocephalus requiring a permanent shunt developed in 22% (n=55) patients. These patients had more often unfavorable outcome compared to patients who did not require insertion of a shunt: unfavorable outcome in 87% (n=48) and 63% (n=117) cases, respectfully (p=0.001). The shunt was inserted usually weeks after aneurysm rupture (median 22 days after SAH).

3.1.2 Age and outcome Age and sex of patient did demonstrate a significant effect on outcome. The median age was 74 years for patients with favorable outcome and 75 years for patients with unfavorable outcome. Six patients were 85 years of age at admission: four of them in good initial condition (HH I-III) and two in poor initial condition (HH IV- V). All six patients aged 85 years had unfavorable outcome. 3.1.3 Medical history A history of stroke or transient ischemic attack appeared to be a risk factor for unfavorable outcome. Unfavorable outcome was seen in 89% (23/26) of these patients compared to 66% (141/214) in other patients (p=0.049). A history of hypertension, a known risk factor for SAH, was seen equally often both in patients with favorable as well as in patients with unfavorable outcome, 46% and 49% respectively. The presence of cardiac disease, chronic respiratory disease or other illness did not affect outcome. Prior medication of oral anticoagulant, aspirin, low molecular weight heparin, clopidogrel or statins was not related to outcome. Warfarin treatment seemed to be a risk factor for the presence of intracerebral or intraventricular blood in CT scan (Fisher grade 4). However, this result was not statistically significant. Only 5% (n=13) of patients were on warfarin treatment. 3.1.4 Clinical grade Initial clinical grade was clearly associated with outcome (p<0.001). At admission 66% (n=166) patients were in good clinical condition (Hunt and Hess grade I-III) and 33% (n=83) were in poor clinical condition (grade IV-V). This data was not available for seven patients.

Of the 166 patients with a good initial clinical grade, 39% (n=64) had favorable outcome and 60% (n=100) had unfavorable outcome. Of the 83 patients with a poor initial clinical grade, only 13% (n=11) had favorable outcome and 87% (n=72) had unfavorable outcome. Poor initial clinical grade seemed to double the risk of death at the three month follow-up. Patients with a good initial clinical grade of WFNS I (43%, n=108) had a 50% chance of achieving favorable outcome. Of the 140 patients with an initial WFNS grade II-V, favorable outcome was achieved in only 16% (n=22) of cases. Table 2. Outcome of 249 patients at three months with respect to their initial clinical condition. GOS HH Good recovery Moderate disability Severe disability Vegetative state Death Total n (%) I 11 2 2 0 0 15 (6) II 33 7 29 5 20 95 (38) III 7 4 22 7 16 57 (23) IV 1 5 22 5 28 62 (25) V 2 2 5 1 10 20 (8) Total n (%) 54 (22) 20(8) 80 (32) 18 (7) 74 (30) 249 (100) 3.1.5 ICH and IVH The amount of blood in the subarachnoid space represented by the Fisher scale and CT findings were strong predictors of outcome at the three month follow-up. Patients with intracerebral hemorrhage (ICH) (n=75) had favorable outcome in only 19% (n=14) of cases compared to 36% (n=53) of patients without ICH (n=149) (p=0.01).

Intraventricular hemorrhage (IVH) (n=69) was also a risk factor for unfavorable outcome. Only 15% (n=10) of patients with IVH achieved favorable outcome in comparison with 37% (n=57) of patients without IVH (n=155) (p=0.001). Patients with both ICH and IVH (n=30) had favorable outcome in only 10% (n=3) cases (p=0.015). Patients with neither ICH nor IVH (n=110) had favorable outcome in 42% (n=46) of cases (p<0.001). Table 3. The presence of intracerebral hemorrhage or intraventricular hemorrhage related to outcome at three month follow-up. GOS Good recovery Moderate disability Severe disability Vegetative state Death Total n (%) ICH 6 8 25 8 28 75 (30) IVH 6 4 20 8 31 69 (27) ICH and IVH 1 2 9 5 13 30 (12) No ICH/IVH All patients 38 8 34 5 24 55 (22) 20 (8) 80 (32) 18 (7) 76 (30) 109 (43) 252 (100) 3.1.6 Aneurysm size and location Neither aneurysm size nor location had significant effect on outcome. The median aneurysm size was 8 mm in patients with favorable outcome and 7 mm in patients with unfavorable outcome. The number of aneurysms detected at the time of diagnosis of asah did not have a significant effect on outcome.

3.1.7 Clipping vs. coiling Patients who had their aneurysm clipped tended to be in better initial clinical condition compared to the endovascularly treated patients. In the clipped group, 68% (n=141) had good and 32% (n=32) poor initial clinical grade whereas in the coiled group the numbers were 54% (n=19) and 43% (n=15), respectively. Also treatment outcome seemed to be more often favorable in patients treated with microneurosurgical clipping compared to patients treated with endovascular techniques, 33% (n=69) and 11% (n=4) cases respectively. The distribution of aneurysm location was different in endovascularly versus microneurosurgically treated patients. In endovascularly treated patients, 60% (n=21) of aneurysms were located in the internal carotid artery compared to 22% (n=46) in clipped patients. In clipped patients, 31% (n=64) had an aneurysm in the middle cerebral artery compared to 6% (n=2) in the endovascularly treated patients (p<0.001). Table 4. Location of the ruptured aneurysm in clipped and coiled patients. ICA MCA A Pericall P Total n (%) Clipped 46 64 66 10 22 208 (83) Coiled 21 2 6 1 5 35 (14) Other 3 3 3 0 0 9 (4) All 70 (28) 69 (27) 75 (30) 11 (4) 27 (11) 252 (100) ICA, internal carotid artery; MCA, middle cerebral artery; A, anterior communicating artery/anterior cerebral artery; Pericall, pericallosal artery; P, posterior circulation

3.1.8 Medical complications Medical complications were common in the elderly asah patients, yet unaffected by the type of treatment. The most common medical complication was pneumonia which developed in over half of the actively treated patients (56%, n=142). Patients with poor initial clinical grade (HH IV-V) had more often postoperative pneumonia compared to patients with good initial clinical grade (HH I-III): 82% (n=68) and 45% (n=74), respectively (p<0.001). Patients who avoided postoperative pneumonia achieved favorable outcome in 50% (n=54) cases compared to 15% (n=21) of cases that had pneumonia (p<0.001). Of all actively treated asah patients, 46% (n=115) suffered postoperative cerebral infarction. Patients with poor initial clinical grade tended to develop this complication more often than others, but this result was not statistically significant. Patients who avoided postoperative cerebral infarction had favorable outcome in 47% (n=58) cases compared to 13% (n=15) of the patients who suffered this complication (p<0.001). Since the initial clinical grade seemed to be associated with occurrence of postoperative pneumonia and cerebral infarction, it is not surprising that these complications were also associated with prolonged treatment at the ICU. The median stay at the ICU was two days for the patients who avoided pneumonia and seven days for the patients who had pneumonia. In the case of brain infarction the numbers were four and seven days, respectively. 3.2 Conservatively treated patients Outcome at discharge seemed to be better in conservatively than actively treated patients. Of the 37 conservatively treated patients, 16% (n=6) had favorable outcome and 73% (n=27) had unfavorable outcome at discharge compared to 9% (n=22) and 90% (n=226) in the actively treated group, respectively. Data on four patients was not available. Of the six patients with favorable outcome at discharge, five had been treated conservatively because of old age and one patient had

refused treatment. Four of them died of SAH later on and three survived for more than five years. Almost half of the conservatively treated patients (46%, n=17) died in hospital compared to 8% (n=19) of the actively treated group. The fatality rate was 68% (n=25) at 3 months compared to 30% (n=76) in the actively treated group. At one year the fatality rate had risen to 78% (n=29) compared to 36% (n=91) in the actively treated group. The conservatively treated patients had the same median age at admission as the actively treated patients. The median aneurysm size was slightly larger (10 mm) compared to actively treated patients (8 mm). We did not find any significant differences between these two patient groups regarding medical history, prior medication, aneurysm number or location. However, the actively treated patients tended to be more often in good initial clinical condition compared to the conservatively treated group. The conservatively treated patients seemed to have more often ICH and IVH in CT scan compared to actively treated group. Table 6. Comparison of conservatively and actively treated patients. n (%) Conservative treatment Active treatment Initial good 17 (46) 166 (66) Initial poor 14 (38) 83 (33) ICH 18 (49) 75 (30) IVH 16 (43) 69 (27) ICH and IVH 11 (30) 30 (12)

Initial clinical grade divided in two groups: good (Hunt and Hess I-III) and poor (Hunt and Hess IV-V); ICH, intracerebral hemorrhage; IVH, intraventricular hemorrhage.

4 Discussion The mean age of asah patients and the proportion of the elderly population in many countries are increasing (3,13). Overall outcome of elderly asah patients has not improved over the years in spite of technological innovations (14-16). We found that the rupture of an intracranial aneurysm has often devastating consequences in the elderly despite active treatment. In our study, the main determinant of outcome after asah was the intensity of the hemorrhage described by CT findings and the initial clinical grade of the patient. Despite the frequency of medical complications, some of the patients achieved a favorable outcome. However, the outcome was most often unsatisfactory and difficult to predict. 4.1 Age and asah In our study of 289 elderly patients with asah, there was a clear increase in the proportion of patients aged 70 years or older during 1980-2007. In our opinion, this reflects (a) the change of attitude in the treatment of SAH from conservative to active operative treatment over the study period as well as (b) an increase in the number of elderly people in the western world, including Finland (17). In Finland the proportion of the population aged 70 years is estimated to increase from 12% to 18% by year 2020 (13). On the other hand, the incidence of asah has been shown to be stable over the last decades (18). At the end of our study period, the elderly accounted for 14% of all asah patients. This percentage is only half of what was found in Japanese studies (19,20) but similar to a European study (21). We expect that the proportion of elderly asah patients will rise in Finland during the next decades. We found asah to be more frequent in elderly women than men. In fact, women outnumbered men by 3.5 to 1 probably because of female preponderance in this age group due to higher life expectancy. This finding is in accordance with other studies (5,22).

4.2 Age and outcome Advanced age is an independent risk factor for poor outcome in asah patients (1,6). We found that the overall outcome in elderly asah patients was in most cases unsatisfactory: only 30% achieved favorable outcome in this study despite active treatment. This result is close to that found in the ISAT study, a more selected study population than ours, where 36% of the corresponding age group achieved favorable outcome (1). In surgical studies where the patients are selected, it has been reported that 39.6-60% of patients have favorable outcome (20,21). In our study, all six patients aged 85 years or older had unfavorable outcome. Based on this finding, we would recommend limiting active treatment for patients above 85 years to only highly selected cases. It has been pointed out that advanced age alone is not a contradiction to surgical treatment of asah in the elderly (5). Fridriksson et al. reported 74% of good results in patients whose initial Hunt and Hess clinical grade was I or II, with these results coming very close to those obtained in younger populations (4). In our study, only 48% of actively treated patients with Hunt and Hess clinical grade I or II had favorable outcome at three months. This difference in favorable outcome is possibly due to a more selected study population in the Swedish study. In our opinion, good grade elderly patients should be still treated actively. Poor grade elderly asah patients have been shown to have a poor outcome despite treatment (23). In our study, poor grade elderly asah patients had favorable outcome in only 13% of cases. As with very old age, poor initial condition should be considered a relative contraindication for active treatment, and should be reserved only for selected cases. 4.3 Factors related to favorable outcome The preoperative condition has been shown to be the most important predictor of asah outcome (23). We found that factors for favorable outcome at three month follow-up included an initial clinical grade of WFNS I, the absence of ICH and IVH in

CT scan and avoidance of postoperative pneumonia and cerebral infarction. Therefore, it seems that the most important factor that determines outcome in elderly asah patients is the severity of SAH which largely determines both the initial clinical grade and the amount of blood and findings in the CT scan. In our opinion, active treatment should be offered to all elderly asah patients who have the chance of recovering to functional independency. The patients who have a good initial clinical grade of WFNS I or absence of ICH and IVH in CT scan are the best candidates. 4.4 Aneurysm location and size and outcome In our study, the size or location of the aneurysm was not associated with outcome. However, the results are inconsistent in previous studies on the subject (24). Patient age seems to have no effect on the size or location of intracranial aneurysms (19). 4.5 Medical history and outcome The preexisting medical condition, compromised cerebral circulation and neural plasticity with advancing age may contribute to an unfavorable outcome after asah in elderly patients (5,6). In our study, we found no association between the preexisting medical conditions and outcome. Hypertension is a known risk factor for asah and it is more frequent in elderly patients (20). However a history of hypertension did not demonstrate effect on outcome and this finding has been confirmed by another study (22). We could not analyze the effect of alcohol abuse and smoking on outcome because of incomplete data. Probably, other factors than preexisting medical conditions are much more important in predicting outcome in the elderly asah patients. We did not find association between aspirin, clopidogrel, warfarin, LMWH or statins medication and outcome. Partly this could have been because of insufficient

number of patients on these drugs. However, oral anticoagulants may be related to a more abundant hemorrhage in CT scan and they are known to increase the risk of intracerebral hemorrhage 7-10 fold (25). There are studies sending positive signals of the potential beneficial effects of statins in preventing delayed ischemic deficits and reducing mortality in asah patients (26). In our study with a small number of patients taking these drugs, statins were not associated with more favorable outcome. 4.6 Factors related to unfavorable outcome We found that factors predicting unfavorable outcome at three month follow-up included: history of stroke or transient ischemic attack; poor initial clinical grade (HH IV-V or WFNS II-V); the presence of ICH and/or IVH in CT scan; occurrence of vasospasm; postoperative pneumonia; postoperative brain infarction; and hydrocephalus requiring permanent shunt. Several of these risk factors are linked to each other; severe asah tends to cause poor clinical grade which in turn predisposes to medical complications and prolonged treatment at the ICU. In these cases the outcome is seldom favorable. History of cerebrovascular disease could be a sign of reduced functional capacity and increased vulnerability of the brain leading to worse outcome after asah. Previous studies have demonstrated that elderly patients have more often poor initial clinical grade and a more abundant hemorrhage in CT scan explaining the worse outcome compared to younger patients (27,28). 4.7 Rebleeding, vasospasm and chronic hydrocephalus Rebleeding of the aneurysm has been found to be more common in elderly patients probably due to atherosclerosis and increased stiffness of the arterial wall (6,14). Also, age-related cerebral atrophy and ventricular enlargement leading to decreased counterpressure can hypothetically predispose to rebleeding.

In our study, rebleeding before operation occurred in 17% of patients. Lanzino et al. had similar results with rebleeding seen in 16% of elderly patients (6,25). Contrary to other studies, we could not demonstrate association between rebleeding and outcome. Nevertheless, early surgery can be assumed to benefit the elderly asah patients in order to prevent rebleeding and treat vasospasm more aggressively (6). The increased stiffness of the arterial wall together with the decreased responsiveness to spasmogenic factors in the elderly patients should result in decreased incidence of vasospasm compared to younger patients. However, due to impairment of cerebral autoregulation of the blood flow, elderly patients are more likely to suffer delayed neurological ischemic deficit caused by vasospasm. In our study, clinically relevant vasospasm occurred in 13% of patients. Ferch et al. found symptomatic vasospasm in 18% of patients 70 years (6). However, the definition of vasospasm can vary between studies making reliable comparison questionable. We found that 22% of patients developed hydrocephalus requiring shunt after asah. Many of these patients had shunt-related complications causing reoperations. Elderly patients are known to have higher incidence of chronic hydrocephalus (21). Reported incidence of hydrocephalus in elderly asah patients varies widely between 4-55% (6,29). 4.8 Conservative treatment In conservatively treated patients with asah the mortality and morbidity rates are known to be high. In a Swedish study of elderly asah patients, 75% suffered morbidity and mortality with more than half of the patients dying within the first three months (21). We had similar results with 73% of conservatively treated patients having unfavorable outcome at discharge. However, even in actively treated patients the results were poor with 69% having an unfavorable outcome at three months. Active treatment seemed to reduce mortality: the mortality rate at three months was 68% for the conservatively and 30% for the actively treated

patients. In elderly patients, active treatment seems prevent deaths without reducing the risk of unfavorable outcome. 4.9 Endovascular and microneurosurgical treatment In many neurosurgical centers, endovascular management is now the treatment of choice in asah and it has been suggested to improve outcome after asah, especially in the elderly (4). However, Karamanakos et al. showed in a retrospective study that the introduction of endovascular treatment did not affect outcome in elderly asah patients (30,31). In our study, we could not reliably compare treatment outcome in coiled and clipped elderly patients because the number of coiled patients was small and the two groups differed in several key parameters. In our opinion, the main determinants for outcome in the elderly asah patient are the severity of the hemorrhage and the initial clinical grade. The method of treatment is of secondary importance and the decision between coiling or clipping should be made on an individual basis in order to minimize procedure - related risk. 4.10 Limitations of this study The fact that this study was retrospective in design causes some limitations. Patients were recruited over a prolonged period of time during which the attitude of treatment changed from conservative to active. Data was incomplete especially for smoking, alcohol abuse and long term follow-up. In our opinion, a short term follow-up is sufficient to make conclusions about asah in the elderly. It is controversial how to treat incidentally found unruptured aneurysms in the elderly (16). Also, it is still difficult to predict which elderly patients will not benefit from active treatment since even poor grade patients can sometimes achieve favorable outcome. As the consequences of aneurysm rupture in the elderly patients are catastrophic even when actively treated, aneurysms should

ideally be treated before rupture at a younger age. In our opinion, research should be focused on prevention of aneurysm formation and early detection of unruptured aneurysms followed by preventive treatment in order to avoid asah altogether.

5 Conclusion The number of elderly asah patients is increasing. Their treatment outcome is often unfavorable despite active treatment. The main determinants of outcome are the severity of the subarachnoid hemorrhage and the initial clinical grade. Active treatment of elderly asah patients seems to prevent deaths without reducing the risk of unfavorable outcome. Patients with WFNS grade I are the best candidates for treatment with a 50% chance of favorable outcome. Poor initial clinical grade can be regarded as a relative contraindication for active treatment. In our study, the outcome of all patients aged 85 years was unfavorable.

6 References (1) Kassell NF, Torner JC, Haley EC, Jane JA, Adams HP, Kongable GL. The International Cooperative Studyon the Timing of Aneurysm Surgery. J Neurosurg 1990 07/01; 2011/11;73(1):18-36. (2) Rinkel GJE, Djibuti M, Algra A, van Gijn J. Prevalence and Risk of Rupture of Intracranial Aneurysms : A Systematic Review. Stroke 1998 January 01;29(1):251-256. (3) Nieuwkamp DJ. Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet neurology 2009;8(7):635. (4) Fridriksson SM. Intracranial aneurysm surgery in the 8th and 9th decades of life: impact on population-based management outcome. Neurosurgery 1995;37(4):627. (5) Inagawa T. Management of elderly patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 1988;69(3):332. (6) Lanzino G. Age and outcome after aneurysmal subarachnoid hemorrhage: why do older patients fare worse? J Neurosurg 1996;85(3):410. (7) Inagawa T. Management outcome in the elderly patient following subarachnoid hemorrhage. J Neurosurg 1993;78(4):554. (8) Johansson M. Changes in intervention and outcome in elderly patients with subarachnoid hemorrhage. Stroke 2001;32(12):2845. (9) Fisher C, Kistler J, Davis J. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 1980 01;6(1):1-9. (10) Hunt WE HR. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 1968 Jan;28(1):14-20. (11) Teasdale GM. A universal subarachnoid hemorrhage scale: report of a committee of the World Federation of Neurosurgical Societies. Journal of neurology, neurosurgery and psychiatry 1988;51(11):1457. (12) Jennett B, Bond M. ASSESSMENT OF OUTCOME AFTER SEVERE BRAIN DAMAGE: A Practical Scale. The Lancet 1975 3/1;305(7905):480-484. (13) Statistics Finland. Population. 2012; Available at: http://www.tilastokeskus.fi/tup/suoluk/suoluk_vaesto_en.html. Accessed 01/2012. (14) Sedat J. Ruptured intracranial aneurysms in the elderly. Neurocrit Care 2005(2):119. (15) Kaminogo M, Yonekura M. Trends in Subarachnoid Haemorrhage in Elderly Persons from Nagasaki, Japan: Analysis of the Nagasaki SAH Data Bank for Cerebral Aneurysm, 1989 1998. Acta Neurochirurgica 2002;144(11):1133-1139.

(16) Karamanakos P, Koivisto T, Vanninen R, Khallaf M, Ronkainen A, Parviainen I, et al. The impact of endovascular management on the outcome of aneurysmal subarachnoid hemorrhage in the elderly in Eastern Finland. Acta Neurochirurgica 2010;152(9):1493-1502. (17) Van der Gaag, van Wissen, van Imhoff, Huisman. National and Regional Population Trends in the European Union. Population and social conditions 1999;3/1999/E/n:o 8. (18) Linn FHH, Rinkel GJE, Algra A, van Gijn J. Incidence of Subarachnoid Hemorrhage : Role of Region, Year, and Rate of Computed Tomography: A Meta-Analysis. Stroke 1996 April 01;27(4):625-629. (19) Horiuchi T. Surgical treatment for aneurysmal subarachnoid hemorrhage in the 8th and 9th decades of life. Neurosurgery 2005;56(469-475). (20) Yamashita K, Kashiwagi S, Kato S, Takasago T, Ito H. Cerebral Aneurysms in the Elderly in Yamaguchi, Japan : Analysis of the Yamaguchi Data Bank of Cerebral Aneurysm From 1985 to 1995. Stroke 1997 October 01;28(10):1926-1931. (21) Ferch R, Pasqualin A, Barone G, Pinna G, Bricolo A. Surgical management of ruptured aneurysms in the eighth and ninth decades. Acta Neurochirurgica 2003;145(6):439-445. (22) Sacco RL, Wolf PA, Bharucha NE, Meeks SL, Kannel WB, Charette LJ, et al. Subarachnoid and intracerebral hemorrhage. Neurology 1984 July 01;34(7):847-847. (23) Yano S, Hamada J. Surgical indications to maintain quality of life in elderly patients with ruptured intracranial aneurysms. Neurosurgery 2003(52):1010. (24) Chung R. Management Outcomes for Ruptured and Unruptured Aneurysms in the Elderly. Neurosurgery 2000;47(4):827. (25) Lan Q, Ikeda H, Jimbo H, Izumiyama H, Matsumoto K. Considerations on surgical treatment for elderly patients with intracranial aneurysms. Surg Neurol 2000 03/01;53(3):231-238. (26) Hart RG, Boop BS, Anderson DC. Oral Anticoagulants and Intracranial Hemorrhage : Facts and Hypotheses. Stroke 1995 August 01;26(8):1471-1477. (27) Sillberg VAH, Wells GA, Perry JJ. Do Statins Improve Outcomes and Reduce the Incidence of Vasospasm After Aneurysmal Subarachnoid Hemorrhage. Stroke 2008 September 01;39(9):2622-2626. (28) Tseng M, Czosnyka M, Richards H, Pickard JD, Kirkpatrick PJ. Effects of Acute Treatment With Pravastatin on Cerebral Vasospasm, Autoregulation, and Delayed Ischemic Deficits After Aneurysmal Subarachnoid Hemorrhage. Stroke 2005 August 01;36(8):1627-1632. (29) Yoshioka H, Inagawa T, Tokuda Y, Inokuchi F. Chronic hydrocephalus in elderly patients following subarachnoid hemorrhage. Surg Neurol 2000 02/01;53(2):119-125.

(30) Jain R, Deveikis J, Thompson BG. Endovascular Management of Poor-Grade Aneurysmal Subarachnoid Hemorrhage in the Geriatric Population. American Journal of Neuroradiology 2004 April 01;25(4):596-600. (31) Sedat J, Dib M, Lonjon M, Litrico S, Von Langsdorf D, Fontaine D, et al. Endovascular Treatment of Ruptured Intracranial Aneurysms in Patients Aged 65 Years and Older. Stroke 2002 November 01;33(11):2620-2625. (32) Vogel T, Verreault R, Turcotte J, Kiesmann M, Berthel M. Review Article. Intracerebral Aneurysms: A Review With Special Attention to Geriatric Aspects. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2003 June 01;58(6):M520- M524.